Nandrolone cyclotate
From Wikipedia, the free encyclopedia
![]() |
|
Clinical data | |
---|---|
Routes of administration |
Intramuscular injection |
Identifiers | |
|
|
Synonyms | RS-3268R |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C28H38O3 |
Molar mass | 422.61 g·mol−1 |
3D model (Jmol) | |
|
|
|
Nandrolone cyclotate (USAN) (developmental code name RS-3268R), or nandrolone ciclotate, also known as 19-nortestosterone 17β-ciclotate, is a synthetic, injected anabolic-androgenic steroid (AAS) of the 19-nortestosterone (nandrolone) group that was never marketed.[1][2][3][4] It is an androgen ester – specifically, the C17β ciclotate (4-methylbicyclo[2.2.2]oct-2-ene-1-carboxylate) ester of nandrolone.[1][2] Nandrolone cyclotate has potent and prolonged activity as an AAS when administered by intramuscular injection and is reported to have a similar duration to that of nandrolone decanoate via this route.[4]
See also[edit]
References[edit]
- ^ a b J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 660–. ISBN 978-1-4757-2085-3.
- ^ a b Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 716–717. ISBN 978-3-88763-075-1.
- ^ I.K. Morton; Judith M. Hall (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. ISBN 978-94-011-4439-1.
- ^ a b van Wayjen, R. G. A.; van den Ende, A. (1973). "CLINICAL-PHARMACOLOGICAL INVESTIGATION OF THE NITROGEN-RETAINING EFFECT OF NANDROLONE CYCLOTATE". European Journal of Endocrinology. 73 (1): 171–178. doi:10.1530/acta.0.0730171. ISSN 0804-4643.
![]() |
This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
![]() |
This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |
![]() |
This article about a steroid is a stub. You can help Wikipedia by expanding it. |